Among emerging anti-diabetic candidates, glucagon like peptide-1 (GLP-1) based therapies carry special cardiovascular implications (Figure 1)
The focus is on sustainable outcomes rather than short-term results
Les agonistes du GLP-1 connaissent un essor considrable, et les laboratoires travaillent dj dvelopper des formes plus pratiques et plus efficaces
A product we often recommend to our clients is Tomorrows Nutrition PRO, Sunfiber ( available on our Fullscript Dispensary )
Expert Opin Investig Drugs 32(5):355359 Urva S, Coskun T, Loh MT, Du Y, Thomas MK, Gurbuz S et al (2022) LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
The serving size is two tablets, taken once daily with a meal